Get the Stockscreener App
2.04
3.32%
-0.07
After Hours:
2.08
0.04
+1.96%
BioStem Technologies, Inc. Common Stock stock is traded at $2.04, with a volume of 102.37K.
It is down -3.32% in the last 24 hours and down -49.13% over the past month.
See More
Previous Close:
$2.11
Open:
$2.15
24h Volume:
102.37K
Relative Volume:
0.90
Market Cap:
$38.09M
Revenue:
Net Income/Loss:
P/E Ratio:
-
EPS:
-
Net Cash Flow:
1W Performance:
-22.73%
1M Performance:
-49.13%
6M Performance:
-56.41%
1Y Performance:
-57.75%
1-Day Range:
$1.8801
$2.30
1-Week Range:
$1.8801
$2.6999
52-Week Range:
$1.8801
$8.40
BioStem Technologies, Inc. Common Stock Stock (BSEM) Company Profile
Name
BioStem Technologies, Inc. Common Stock
Sector
Industry
Phone
-
Address
-
Compare BSEM vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BSEM
BioStem Technologies, Inc. Common Stock
|
2.04 | 38.09M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
508.75 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.34 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.27 | 53.22B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.08 | 42.32B | 5.76B | 514.49M | 1.10B | 4.4813 |
BioStem Technologies, Inc. Common Stock Stock (BSEM) Latest News
BioStem Technologies Completes $3 Million Private Placement Financing - The Globe and Mail
BioStem Technologies Completes $3 Million Private Stock and Warrants Offering - Kalkine Media
BioStem Technologies Secures $3 Million Private Placement; Issues Stock at $4.08 and Warrants - TradingView
BioStem Technologies raises $3M in private placement By Investing.com - Investing.com South Africa
BioStem Technologies raises $3M in private placement - Investing.com
BioStem Technologies Announces $3 Million Private Placement Priced At-The-Market Under Nasdaq Rules - GlobeNewswire
BioStem (BSEM) lines up $40M in potential stock sales—how much has it tapped? - Stock Titan
BioStem Technologies Establishes $40 Million Committed Equity Facility With Roth Principal Investments - TradingView
New stock sale deal could fund BioStem (NASDAQ: BSEM) for up to three years - Stock Titan
BioStem Technologies Secures Access to $40 Million Equity Facility - citybiz
BioStem Technologies Secures Up to $40 Million in a Committed Equity Facility - GlobeNewswire
BioStem (NASDAQ: BSEM) lines up $40M stock deal that could dilute investors - Stock Titan
Up to $40 million in shares could be sold by BioStem. It does not have to use the facility. - Stock Titan
BioStem Technologies (BSEM) CAO increases direct holdings with RSU share conversion - Stock Titan
BioStem Technologies (BSEM) director now holds 33,928 shares after RSU exercise - Stock Titan
BioStem Technologies (BSEM) CEO receives 25K shares via RSUs - Stock Titan
BioStem Technologies (BSEM) CFO lifts direct stake to 58,062 shares - Stock Titan
BioStem Technologies (BSEM) insider adds 17,196 shares at $0 - Stock Titan
BioStem Technologies (BSEM) CCO adds 500 shares through equity award - Stock Titan
BioStem Technologies (BSEM) director gains 7,671 shares - Stock Titan
BioStem Technologies Reports Second Quarter 2026 Financial Results - GlobeNewswire
BioStem Technologies wins Nasdaq approval, begins trading August 7 - Dealroom
BioStem Technologies (Nasdaq:BSEM)Stock Analysis - Simply Wall Street
BioStem Technologies, Inc. (BSEM) Company Information - Simply Wall Street
BioStem Technologies Uplists to Nasdaq Capital Market - The Globe and Mail
symbol__ Stock Quote Price and Forecast - CNN
BioStem Technologies Uplists to Nasdaq Capital Market - TipRanks
BioStem Technologies Announces Nasdaq Uplisting - GlobeNewswire
BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission - Yahoo Finance
BioStem Technologies, Inc. Common Stock Stock (BSEM) Financials Data
There is no financial data for BioStem Technologies, Inc. Common Stock (BSEM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
BioStem Technologies, Inc. Common Stock Stock (BSEM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Matuszewski Jason | Chief Executive Officer |
Oct 07 '26 |
Option Exercise |
2.00 |
250,000 |
500,000 |
1,553,551 |
| SMITH-VAN VURST ANDREW | Chief Operating Officer |
Sep 17 '26 |
Option Exercise |
0.00 |
9,574 |
0 |
1,539,809 |
| Matuszewski Jason | Chief Executive Officer |
Sep 17 '26 |
Option Exercise |
0.00 |
16,650 |
0 |
1,303,552 |
| SMITH-VAN VURST ANDREW | Chief Operating Officer |
Sep 15 '26 |
Option Exercise |
0.00 |
7,622 |
0 |
1,530,235 |
| POE BRANDON | Chief Financial Officer |
Sep 15 '26 |
Option Exercise |
0.00 |
1,694 |
0 |
58,062 |
| Matuszewski Jason | Chief Executive Officer |
Sep 15 '26 |
Option Exercise |
0.00 |
8,469 |
0 |
1,286,902 |
| WARRINGTON KENNETH HOWARD JR | Director |
Sep 15 '26 |
Option Exercise |
0.00 |
1,694 |
0 |
33,928 |
| FORTUNATO MICHAEL A | Chief Accounting Officer |
Sep 15 '26 |
Option Exercise |
0.00 |
4,234 |
0 |
68,664 |
| HASSETT BARRY | Chief Commercial Officer |
Sep 09 '26 |
Option Exercise |
0.00 |
500 |
0 |
5,003 |
| UNGRODT JODI | Director |
Aug 27 '26 |
Option Exercise |
0.00 |
5,647 |
0 |
11,295 |
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):